TARDBP and amyotrophic lateral sclerosis: We have previously demonstrated the usefulness of lymphoblastoid cell lines derived from patients to study TDP-43 homeostasis [27,30] being a suitable platform for preclinical evaluation of potential drug candidates for TDP-43 proteinopathies such as Frontotemporal Dementia (FTD) or ALS [35].